Sulfisoxazole from Japan
Sulfisoxazole is a short-acting sulfonamide antibiotic effective against a wide range of gram-positive and gram-negative bacteria, commonly used in pediatric ear infections and urinary tract infections. It qualifies for HTS 2935.90.60.00 as a sulfonamide drug meeting Chapter 29 criteria for separate chemically defined organic compounds used pharmaceutically. The molecule features the classic p-aminobenzenesulfonamide structure.
Duty Rate — Japan → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit FDA registration and drug listing numbers for the manufacturing facility to expedite clearance
• Include microbial limit testing results as sulfonamides are prone to contamination issues during import
• Avoid bulk packaging that suggests industrial use to maintain pharmaceutical classification